Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Lopez

Showing results (11-20 of 414) with videos related to

Pageof 42
Sort By:
Advanced Drug Delivery Reviews|January 4, 2014
Liposomal siRNA nanocarriers for cancer therapyBulent Ozpolat, Anil K Sood, Gabriel Lopez-Berestein
Journal of Cognition and Development : Official Journal of the Cognitive Development Society|January 14, 2012
Development of the use of conversational cues to assess reality statusJacqueline D Woolley, Lili Ma, Gabriel Lopez-Mobilia
Mini Reviews in Medicinal Chemistry|March 14, 2008
Strategies for in vivo siRNA delivery in cancerAngela Sanguino, Gabriel Lopez-Berestein, Anil K Sood
Integrative Cancer Therapies|October 28, 2021
Implementing Telehealth Music Therapy Services in an Integrative Oncology Setting: A Case SeriesSarah Folsom, Aimee J Christie, Lorenzo Cohen, et al.
The Science of the Total Environment|January 15, 2019
Corruption and conflicts as barriers to adaptive governance: Water governance in dryland systems in the Rio del Carmen watershedGabriel Lopez Porras, Lindsay C Stringer, Claire H Quinn
Methods in Enzymology|June 3, 2004
Liposomal antisense oligonucleotides for cancer therapyDoris R Siwak, Ana M Tari, Gabriel Lopez-Berestein
Autophagy|May 18, 2007
PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cellsBulent Ozpolat, Ugur Akar, Kapil Mehta, et al.
Plos One|August 12, 2022
Pretransplant survival of patients with end-stage heart failure under competing risksKevin B Smith, Tseeye Odugba Potters, Gabriel Lopez Zenarosa
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002Doris R Siwak, Ana M Tari, Gabriel Lopez-Berestein
Methods in Enzymology|February 22, 2005
Liposomal polyene antibioticsAgatha W K Ng, Kishor M Wasan, Gabriel Lopez-Berestein
Pageof 42

Showing results (11-20 of 414) with videos related to

Sort By:
Pageof 42
Advanced Drug Delivery Reviews|January 4, 2014
Liposomal siRNA nanocarriers for cancer therapyBulent Ozpolat, Anil K Sood, Gabriel Lopez-Berestein
Journal of Cognition and Development : Official Journal of the Cognitive Development Society|January 14, 2012
Development of the use of conversational cues to assess reality statusJacqueline D Woolley, Lili Ma, Gabriel Lopez-Mobilia
Mini Reviews in Medicinal Chemistry|March 14, 2008
Strategies for in vivo siRNA delivery in cancerAngela Sanguino, Gabriel Lopez-Berestein, Anil K Sood
Integrative Cancer Therapies|October 28, 2021
Implementing Telehealth Music Therapy Services in an Integrative Oncology Setting: A Case SeriesSarah Folsom, Aimee J Christie, Lorenzo Cohen, et al.
The Science of the Total Environment|January 15, 2019
Corruption and conflicts as barriers to adaptive governance: Water governance in dryland systems in the Rio del Carmen watershedGabriel Lopez Porras, Lindsay C Stringer, Claire H Quinn
Methods in Enzymology|June 3, 2004
Liposomal antisense oligonucleotides for cancer therapyDoris R Siwak, Ana M Tari, Gabriel Lopez-Berestein
Autophagy|May 18, 2007
PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cellsBulent Ozpolat, Ugur Akar, Kapil Mehta, et al.
Plos One|August 12, 2022
Pretransplant survival of patients with end-stage heart failure under competing risksKevin B Smith, Tseeye Odugba Potters, Gabriel Lopez Zenarosa
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002Doris R Siwak, Ana M Tari, Gabriel Lopez-Berestein
Methods in Enzymology|February 22, 2005
Liposomal polyene antibioticsAgatha W K Ng, Kishor M Wasan, Gabriel Lopez-Berestein
Pageof 42